Jeffrey L Nelson

Title: The Innovative Contributions of Jeffrey L. Nelson

Introduction

Jeffrey L. Nelson is a notable inventor based in Dublin, Ohio. He has made significant contributions to the field of medical treatments, particularly in addressing diabetic ulcers. His innovative approach combines various compounds to enhance healing in diabetic individuals.

Latest Patents

Jeffrey L. Nelson holds a patent for a unique combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for use in treating diabetic ulcers. This patent discloses a method for treating diabetic ulcers in individuals with specific health indicators, such as a serum albumin level of less than or equal to 4.0 g/dL and/or an Ankle-Brachial Index of less than 1.0. The combination can be administered orally via a nutritional composition, providing a novel approach to managing this challenging condition.

Career Highlights

Throughout his career, Jeffrey has been associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work has focused on developing effective treatments that improve patient outcomes, particularly for those suffering from diabetes-related complications.

Collaborations

Jeffrey has collaborated with esteemed colleagues, including Anne C. Voss and Maria G. Baggs. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jeffrey L. Nelson's contributions to the field of medical treatment for diabetic ulcers highlight his innovative spirit and dedication to improving healthcare. His patent reflects a significant advancement in the management of diabetic conditions, showcasing the importance of research and collaboration in the medical field.